fbpx
Category

Investing

Category

Key Takeaways Bill Gates believes we can predict the future of global health. His belief is based on three fundamental facts from the past that define the current state of this industry: dramatic improvements in recent decades, consistent innovations that bring forth more improvements, and long-term effects of today’s innovations.The two key improvements that Bill Gates expects to take place in the next 20 years are the elimination of malnutrition and a shift from a…

Key Takeaways The business of longevity is growing at a staggering rate, and this is projected to continueThe total funding of longevity studies is currently estimated to be between $850 million to $300 billionSeniors are the fastest-growing consumer group worldwide, and their collective spending power is expected to reach USD 15 trillion by 2020. This makes the longevity industry one of the most profitable industries at the moment – and in the long run Actions…

Introducing David Sinclair, The Einstein of Longevity? David Sinclair just came out with a book, Lifespan. He’s one of the experts I’ve been following most closely in longevity, next to Peter Attia and Aubrey de Grey, due to his extensive list of accomplishments across disciplines, all tunnel-visioned towards this problem. He’s been heads-down on solving aging for over thirty years, as a professor and published researcher at Harvard, co-founder of the journal Aging, co-founder of…

1. The addressable market size is everyone. Not just people 65+. Longevity can and should start being solved at a young age. Everyone dies, most everyone cares and thinks about this. Warren Buffett said it right, “You have only one mind and one body for the rest of your life. If you aren’t taking care of them when you’re young, it’s like leaving that car out in hailstorms and letting rust eat away at it. By the…

“My sense is that economic incentives of drugs companies are screwed up” says Altman. “I don’t think we have enough people saying, How can we make a lot of people a lot heathier?”  Longevity startups that make it through the iron gates of YC would get $500,000 to $1 million in exchange for 20% equity, lab space, and advice. This was early last year, looks the the opportunity is still wide open. Read full article here

Vice president of Juvenescence-backed AgeX, Aubrey de Grey, ambitiously claims that that longevity industry will “dwarf the dotcom boom.” This is a growing space due to an aging population alongside accelerating technology, burgeoning research, and the growing epidemic of chronic illnesses. The 4 markets in longevity: Geroscience R&D: identifying the underlying biomedical mechanisms to aging and research methods for targeting them in order to delay or reverse aging.P4 Medicine: personalized, precision, preventative, participatory. This includes…